TELETRADER News
11/30/2020, 12:38 PM (Source: TeleTrader)
more TeleTrader news

Novavax-1.94%

127.42
Chart for: Novavax

Novavax advances study on COVID-19 vaccine

Novavax Inc. announced on Monday the company has completed enrollment of its COVID-19 vaccine candidate in the United Kingdom and South Africa, while the last trial phase in the United States and Mexico is set to start in the upcoming weeks.

"We continue to make meaningful progress as we work to test, manufacture and ultimately deliver NVX-CoV2373 with unprecedented speed, as well as put partnerships in place that would ensure widespread and equitable access worldwide," Chief Executive Stanley Erck noted.

The first interim results of trials involving over 20,000 people should be expected in the first quarter of the next year, the statement concluded.

Breaking the News / ND